Detalhe da pesquisa
1.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
2.
Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care.
Breast Cancer Res Treat
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38676808
3.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112922
4.
Development of a comprehensive approach to adult hereditary cancer testing in Ontario.
J Med Genet
; 60(8): 769-775, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564171
5.
A model for the return and referral of all clinically significant secondary findings of genomic sequencing.
J Med Genet
; 60(8): 733-739, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217257
6.
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutations.
Hered Cancer Clin Pract
; 22(1): 7, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38741145
7.
Breast Magnetic Resonance Imaging for Preoperative Evaluation of Breast Cancer: A Systematic Review and Meta-Analysis.
Can Assoc Radiol J
; 75(1): 118-135, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593787
8.
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
Cancer
; 129(6): 901-907, 2023 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36571512
9.
Great expectations: patients' preferences for clinically significant results from genomic sequencing.
Hum Genet
; 142(4): 553-562, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943453
10.
Estimating the incidence of breast cancer recurrence using administrative data.
Breast Cancer Res Treat
; 198(3): 509-522, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422755
11.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
12.
Validation of the International Breast Cancer Intervention Study (IBIS) model in the High Risk Ontario Breast Screening Program: A retrospective cohort study.
Genet Med
; 25(6): 100820, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919844
13.
A comprehensive genomic reporting structure for communicating all clinically significant primary and secondary findings.
Hum Genet
; 141(12): 1875-1885, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35739291
14.
Impact of body mass index on survival in women receiving chemotherapy for early breast cancer.
Breast Cancer Res Treat
; 196(2): 329-339, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36114940
15.
Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning.
Breast Cancer Res Treat
; 191(3): 631-641, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846626
16.
The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT.
Clin Genet
; 101(3): 317-323, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34897671
17.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
18.
Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
Can J Surg
; 65(2): E250-E256, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35365498
19.
Factors associated with waiting time to breast cancer diagnosis among symptomatic breast cancer patients: a population-based study from Ontario, Canada.
Breast Cancer Res Treat
; 187(1): 225-235, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486544
20.
Psychological consequences of MRI-based screening among women with strong family histories of breast cancer.
Breast Cancer Res Treat
; 189(2): 497-508, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213659